While the linguistic feats of ChatGPT and other chatbots have been capturing headlines, researchers at Montana State University have been steadily advancing another, more ordinary — and potentially life-saving — application of artificial intelligence: helping to diagnose and treat prostate cancer.
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and older
The panel’s decision moves the U.S. one step closer to making jabs against respiratory syncytial virus available to the public this fall, when the disease typically begins to spread at higher levels.
Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics
Microbion Corporation has announced that the company has been selected to present a poster highlighting the results from an E. coli CRISPR/Cas gene expression knockdown study characterizing pravibismane’s mechanism of action at the ASM Microbe Conference to be held in Houston, TX from June 15-19th, 2023.
CSBI Releases the 2023 Life Sciences Workforce Trends Report at BIO International Convention
The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.
MSU Extension and Montana Department of Agriculture join new USDA regional food business center partnership
Montana State University Extension and the Montana Department of Agriculture were recently announced as partners in a $30 million U.S. Department of Agriculture effort to establish a regional center to create opportunities for food producers and increase food security.
Tonix Pharmaceuticals Announces the Isolation and Characterization of the (S)-Isomer of Tianeptine
TNX-4300’s Mechanism of Restoring Neuroplasticity Supports Development as a First-in-Class Oral Therapy for Depression, Bipolar Disorder, Alzheimer’s Disease and Parkinson’s Disease
FDA approves first RSV vaccine
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.
Microbion Corp. Granted US Patent for the Use of Inhaled Pravibismane for Pulmonary Infections
Extends patent protection for Microbion’s proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039.
NIH Entrepreneurship News
Information on Small Business Funding Webinar, National Small Business Week, America’s SEED Fund Week — and more